| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0019300 | Intron-Exon-Intron | chr7:122375018-122377122 | chr7:122734964-122737068 | 2105 nt | 0.3558 |
| hsa_CADPS2_0019700 | Intron-Exon-Intron | chr7:122377009-122427665 | chr7:122736955-122787611 | 114 nt | 0.4386 |
| hsa_CADPS2_0019600 | Intron-Exon-Intron | chr7:122377009-122430449 | chr7:122736955-122790395 | 250 nt | 0.4080 |
| hsa_CADPS2_0019800 | Intron-Exon-Intron | chr7:122377009-122504718 | chr7:122736955-122864664 | 114 nt | 0.4386 |
| hsa_CADPS2_0019900 | Intron-Intron | chr7:122392153-122392505 | chr7:122752099-122752451 | 353 nt | 0.2691 |
| hsa_chr7_0100400 | Intergenic-Intergenic | chr7:122406181-122406457 | chr7:122766127-122766403 | 277 nt | 0.3935 |
| hsa_CADPS2_0020000 | Intron-Intron | chr7:122414387-122420253 | chr7:122774333-122780199 | 250 nt | 0.1880 |
| hsa_chr7_0100500 | Intergenic-Intergenic | chr7:122424675-122424859 | chr7:122784621-122784805 | 185 nt | 0.3784 |
| hsa_CADPS2_0020100 | Intron-Intron | chr7:122424985-122425591 | chr7:122784931-122785537 | 607 nt | 0.3608 |
| hsa_CADPS2_0020300 | Intron-Intron | chr7:122427594-122429184 | chr7:122787540-122789130 | 261 nt | 0.4559 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].